Search

Search Results
Results 7831 - 7840 of 9443 for emergency medicine
  • Capvaxive
    Drug - 4 May 2026
    Consumer Medicine Information (CMI) about Capvaxive intended for persons living in Australia.
  • Keytruda
    Drug - 1 May 2026
    Consumer Medicine Information (CMI) about Keytruda intended for persons living in Australia.
  • Tecentriq SC
    Drug - 30 Apr 2026
    Consumer Medicine Information (CMI) about Tecentriq SC intended for persons living in Australia.
  • Tecentriq
    Drug - 30 Apr 2026
    Consumer Medicine Information (CMI) about Tecentriq intended for persons living in Australia.
  • Lazcluze
    Drug - 30 Apr 2026
    Consumer Medicine Information (CMI) about Lazcluze intended for persons living in Australia.
  • TikTok chatter could help predict where the opioid crisis is heading next
    News - 28 Apr 2026
    A large-scale analysis of 569,581 TikTok comments found that opioid-related discussions may help track and forecast synthetic opioid overdose mortality in the US. Recovery, harm reduction, drug use,...
  • Cabenuva
    Drug - 24 Apr 2026
    Consumer Medicine Information (CMI) about Cabenuva intended for persons living in Australia.
  • Paxlovid speeds recovery but does not reduce severe COVID outcomes in vaccinated adults
    News - 22 Apr 2026
    Paxlovid (nirmatrelvir-ritonavir) does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe COVID-19, despite helping them recover faster, according to results from...
  • Nexviazyme
    Drug - 22 Apr 2026
    Consumer Medicine Information (CMI) about Nexviazyme intended for persons living in Australia.
  • Zolgensma
    Drug - 22 Apr 2026
    Consumer Medicine Information (CMI) about Zolgensma intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback